lung cancer | |||||
新闻 | |||||
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future In terms of indications, the largest number of trials involved three or more unspecified solid tumors (50/199, 25.1%), followed by non-small cell lung ...
| |||||
BGNE - BeiGene, Ltd. American Depositary Shares Latest Stock News & Market Updates ... Lung Cancer in China. Rhea-AI Summary. BeiGene, Ltd. (NASDAQ: BGNE) announced that the Center for Drug Evaluation of China's NMPA accepted a ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment